Adventa BhdXKLS:7191 29 EBIT per Share is RM-0.02 as of Mar. 2026. GuruFocus rates XKLS:7191 with a GF Score™ of 29/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 689 Medical Devices & Instruments companies, Adventa Bhd ranks worse than 85.05% on this metric.
Adventa Bhd's EBIT per Share for the
three
months ended in Mar. 2026 was RM-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM-0.02.
During the past 12 months, the average EBIT per Share Growth Rate of Adventa Bhd was -550.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -21.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Adventa Bhd's EBIT per Share or its related term are showing as below:
XKLS:7191'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -61.5 Med: 17.4 Max: 32.8
Current: -21.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Adventa Bhd was 32.80% per year. The lowest was -61.50% per year. And the median was 17.40% per year.
XKLS:7191's 3-Year EBIT Growth Rate is ranked worse than 85.05% of 689
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs XKLS:7191: -21.60
Adventa Bhd's EBIT for the
three
months ended in Mar. 2026 was RM-1.66 Mil.
Adventa Bhd (XKLS:7191) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Adventa Bhd EBIT per Share Related Terms
Adventa Bhd EBIT per Share Historical Data
* Premium members only.
The historical data trend for Adventa Bhd's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adventa Bhd (XKLS:7191) has a EBIT per Share of RM-0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Adventa Bhd and its competitors. According to the industry distribution chart, Adventa Bhd ranks #586 out of 689 companies in the Medical Devices & Instruments industry, placing it in the top 85.1%.
Is Adventa Bhd's EBIT per Share too high?
Adventa Bhd's current EBIT per Share is RM-0.02. Based on the distribution chart, Adventa Bhd ranks #586 out of 689 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adventa Bhd has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #586 out of 689 companies for EBIT per Share. This places Adventa Bhd in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Adventa Bhd and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adventa Bhd's current EBIT per Share is RM-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 47.9% below its estimated fair value. The current EBIT per Share is RM-0.02. Adventa Bhd's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current EBIT per Share is RM-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adventa Bhd (XKLS:7191) Overvalued in 2026?
Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued.
The current stock price of RM0.13 is trading 47.9% below its estimated GF Value™ of RM0.24.
GuruFocus considers Adventa Bhd to be Possible Value Trap.
Key valuation signals for XKLS:7191:
EBIT per Share: RM-0.02
GF Value™: RM0.24 vs. price of RM0.13 (47.9% below fair value)
No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
29GF Score
Get the complete analysis for XKLS:7191
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7191 has been successfully added to your 
